Myelomas
C16038: An Open-Label, Single-Arm, Multicenter Study to Evaluate the Effectiveness and Safety of Ixazomib (NINLARO�) in Combination with Lenalidomide and Dexamethasone (IRD) in Patients with Multiple Myeloma Previously Receiving a Bortezomib-Based Triplet Induction Regimen (Phase IV)
- Details
ClinicalTrials.gov ID:
NCT03173092
Diagnosis Type:
NA
USOR Number:
- Address
8196 Walnut Hill Lane, Suite 100
Dallas, TX 75231
P: (214) 345-7394